Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xiu Yu

Showing results (401-410 of 412) with videos related to

Pageof 42
Sort By:
Journal of Cancer|November 21, 2017
Loss of LKB1 Expression Decreases the Survival and Promotes Laryngeal Cancer MetastasisSha-Sha He, Yong Chen, Hong-Zhi Wang, et al.
Cell Metabolism|November 18, 2023
The tRNA-GCN2-FBXO22-axis-mediated mTOR ubiquitination senses amino acid insufficiencyMeng-Kai Ge, Cheng Zhang, Na Zhang, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 24, 2009
KIT kinase mutants show unique mechanisms of drug resistance to imatinib and sunitinib in gastrointestinal stromal tumor patientsKetan S Gajiwala, Joe C Wu, James Christensen, et al.
Nature Communications|August 14, 2023
Camrelizumab combined with apatinib in patients with first-line platinum-resistant or PD-1 inhibitor resistant recurrent/metastatic nasopharyngeal carcinoma: a single-arm, phase 2 trialLi Yuan, Guo-Dong Jia, Xiao-Fei Lv, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|December 19, 2012
Case-control study of diet in patients with cervical cancer or precancerosis in Wufeng, a high incidence region in ChinaYao Jia, Ting Hu, Chuan-Ying Hang, et al.
BMC Medicine|March 17, 2023
The efficacy and safety of apatinib plus capecitabine in platinum-refractory metastatic and/or recurrent nasopharyngeal carcinoma: a prospective, phase II trialLin-Quan Tang, Xiao-Yun Li, Zhi-Ming Li, et al.
EMBO Reports|March 2, 2018
SIRT5 inhibits peroxisomal ACOX1 to prevent oxidative damage and is downregulated in liver cancerXiu-Fei Chen, Meng-Xin Tian, Ren-Qiang Sun, et al.
Ebiomedicine|June 25, 2020
Identification of susceptibility variants to benign childhood epilepsy with centro-temporal spikes (BECTS) in Chinese Han populationXiu-Yu Shi, Geng Wang, Ting Li, et al.
World Journal of Pediatrics : WJP|January 2, 2025
Diagnosis and treatment recommendations for glucose transporter 1 deficiency syndromeMei-Jiao Zhang, De Wu, Li-Fei Yu, et al.
Journal of Medicinal Chemistry|August 12, 2016
Design and Synthesis of Pyridone-Containing 3,4-Dihydroisoquinoline-1(2H)-ones as a Novel Class of Enhancer of Zeste Homolog 2 (EZH2) InhibitorsPei-Pei Kung, Eugene Rui, Simon Bergqvist, et al.
Pageof 42

Showing results (401-410 of 412) with videos related to

Sort By:
Pageof 42
Journal of Cancer|November 21, 2017
Loss of LKB1 Expression Decreases the Survival and Promotes Laryngeal Cancer MetastasisSha-Sha He, Yong Chen, Hong-Zhi Wang, et al.
Cell Metabolism|November 18, 2023
The tRNA-GCN2-FBXO22-axis-mediated mTOR ubiquitination senses amino acid insufficiencyMeng-Kai Ge, Cheng Zhang, Na Zhang, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 24, 2009
KIT kinase mutants show unique mechanisms of drug resistance to imatinib and sunitinib in gastrointestinal stromal tumor patientsKetan S Gajiwala, Joe C Wu, James Christensen, et al.
Nature Communications|August 14, 2023
Camrelizumab combined with apatinib in patients with first-line platinum-resistant or PD-1 inhibitor resistant recurrent/metastatic nasopharyngeal carcinoma: a single-arm, phase 2 trialLi Yuan, Guo-Dong Jia, Xiao-Fei Lv, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|December 19, 2012
Case-control study of diet in patients with cervical cancer or precancerosis in Wufeng, a high incidence region in ChinaYao Jia, Ting Hu, Chuan-Ying Hang, et al.
BMC Medicine|March 17, 2023
The efficacy and safety of apatinib plus capecitabine in platinum-refractory metastatic and/or recurrent nasopharyngeal carcinoma: a prospective, phase II trialLin-Quan Tang, Xiao-Yun Li, Zhi-Ming Li, et al.
EMBO Reports|March 2, 2018
SIRT5 inhibits peroxisomal ACOX1 to prevent oxidative damage and is downregulated in liver cancerXiu-Fei Chen, Meng-Xin Tian, Ren-Qiang Sun, et al.
Ebiomedicine|June 25, 2020
Identification of susceptibility variants to benign childhood epilepsy with centro-temporal spikes (BECTS) in Chinese Han populationXiu-Yu Shi, Geng Wang, Ting Li, et al.
World Journal of Pediatrics : WJP|January 2, 2025
Diagnosis and treatment recommendations for glucose transporter 1 deficiency syndromeMei-Jiao Zhang, De Wu, Li-Fei Yu, et al.
Journal of Medicinal Chemistry|August 12, 2016
Design and Synthesis of Pyridone-Containing 3,4-Dihydroisoquinoline-1(2H)-ones as a Novel Class of Enhancer of Zeste Homolog 2 (EZH2) InhibitorsPei-Pei Kung, Eugene Rui, Simon Bergqvist, et al.
Pageof 42